Posted by Michael Wonder on 15 May 2023
ICER to assess treatment for pulmonary arterial hypertension
15 May 2023 - Report will be subject of Midwest CEPAC meeting in December 2023; draft scoping document open to public comment until 5 June 2023.
The ICER announced today that it will assess the comparative clinical effectiveness and value of sotatercept (Merck/MSD) for pulmonary arterial hypertension.
